| |
| |
|
| Insider
Information: |
Quisel John D |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
122,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,752,747 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
122,381 |
|
|
| Total
Value |
$11,752,747 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
EVP, Chief Business Of... |
2020-01-02 |
53,316 |
2014-04-22 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-01-10 |
69,065 |
2023-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2017-09-13 |
4 |
AS |
$38.03 |
$304 |
D/D |
(8) |
57,310 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-04-03 |
4 |
AS |
$38.33 |
$46,232 |
D/D |
(1,204) |
56,598 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Bus. Dev., GC & Secretary |
• – – |
2017-01-04 |
4 |
AS |
$26.43 |
$46,513 |
D/D |
(1,700) |
54,523 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP General Counsel & Secretary |
• – – |
2014-04-22 |
4 |
OE |
$0.92 |
$1,840 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
VP General Counsel & Secretary |
• – – |
2014-04-22 |
4 |
AS |
$35.75 |
$71,690 |
D/D |
(2,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-09-12 |
4 |
OE |
$0.92 |
$1,840 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-09-12 |
4 |
AS |
$25.43 |
$50,860 |
D/D |
(2,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
58,598 |
0 |
- |
|
| IRON |
Disc Medicine, Inc |
Chief Executive Officer |
• • – |
2023-12-29 |
4 |
OE |
$1.01 |
$2,727 |
D/D |
2,700 |
2,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, Chief Business Officer |
• – – |
2019-09-10 |
4 |
AS |
$45.23 |
$162,104 |
D/D |
(3,584) |
59,158 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$44.24 |
$161,671 |
D/D |
(3,622) |
53,834 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-10-14 |
4 |
AS |
$29.02 |
$116,080 |
D/D |
(4,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-10-14 |
4 |
OE |
$0.92 |
$3,680 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-11-14 |
4 |
OE |
$0.92 |
$3,680 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-11-14 |
4 |
AS |
$33.24 |
$133,959 |
D/D |
(4,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-12-12 |
4 |
OE |
$0.92 |
$3,680 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-12-12 |
4 |
AS |
$40.72 |
$165,380 |
D/D |
(4,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-03-13 |
4 |
OE |
$5.08 |
$20,320 |
D/D |
4,000 |
19,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2015-03-13 |
4 |
AS |
$41.28 |
$165,736 |
D/D |
(4,000) |
15,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-01-02 |
4 |
AS |
$42.42 |
$183,806 |
D/D |
(4,333) |
52,977 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
EVP, CBO and Secretary |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
57,456 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, Corp. Dev., GC & Sec. |
• – – |
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,825 |
57,802 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-07-14 |
4 |
AS |
$28.70 |
$148,669 |
D/D |
(5,000) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-07-14 |
4 |
OE |
$0.92 |
$17,680 |
D/D |
5,000 |
3,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP Gen. Counsel & Secretary |
• – – |
2014-11-12 |
4 |
OE |
$5.88 |
$31,755 |
D/D |
5,000 |
5,000 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
